CVE-2026-105176 SourceCodester CVE debrief

Who should care

Defenders responsible for SourceCodester Drug Recommendation System 1.0 deployments should assess exposure and prioritize patching or mitigation to prevent potential data manipulation or extraction of sensitive information through SQL injection attacks. This includes verifying the presence of this vulnerability in their systems, applying patches or mitigations as available, and monitoring for potential exploitation attempts.

Why it matters

Defenders should care about CVE-2026-105176 because it represents a SQL injection vulnerability in SourceCodester Drug Recommendation System 1.0, which could allow attackers to manipulate data or extract sensitive information. The vulnerability has been publicly disclosed and may be utilized by attackers.

• Verify potential exposure to SQL injection attacks
• Assess the impact of a successful exploit on data confidentiality and integrity
• Prioritize patching or mitigation to prevent exploitation

Technical summary

A SQL injection vulnerability exists in the /Admin/edit_class.php file of SourceCodester Drug Recommendation System 1.0. The vulnerability is caused by improper sanitization of user input in the ID argument. This could allow attackers to manipulate data or extract sensitive information. Defenders should prioritize verifying the presence of this vulnerability in their systems and applying patches or mitigations as available to prevent potential exploitation attempts through SQL injection attacks on the affected system.

Defensive priority

Defenders should prioritize verifying the presence of this vulnerability in their systems and applying patches or mitigations as available.

Recommended defensive actions

• Verify the presence of this vulnerability in your systems
• Apply patches or mitigations as available
• Monitor for potential exploitation attempts
• Review compensating controls for exposed systems while remediation is scheduled and verified
• Check relevant monitoring, detection, and logs for exposed assets that need extra review
• Track exceptions, retest remediated assets, and close the item only after evidence is documented
• Confirm whether affected product deployments exist in managed environments and assign an owner for follow-up

Evidence notes

The CVE record and NVD entry provide limited information about the vulnerability. Further verification is required to determine the affected versions and potential impact. The vulnerability has been publicly disclosed, and defenders should verify the presence of this vulnerability in their systems and apply patches or mitigations as available.

Sources and references

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.